Biofeedback devices market seen reaching $5.96 billion by 2030

The biofeedback devices market is projected to grow from $4.06 billion in 2026 to $5.96 billion by 2030, according to The Business Research Company. Rising stress-related disorders, digital mental health demand and remote therapy adoption are among the main forces behind the forecast.

Why it matters: - Biofeedback devices are moving from niche wellness tools into broader use in stress management, rehabilitation and digital mental health. - The market’s forecast growth signals stronger demand for non-pharmacological tools that help users monitor and regulate heart rate, muscle tension and brain activity. - The shift could accelerate adoption of wearable, home-based and mobile-connected therapies.

What happened: - The biofeedback devices market is projected to rise from $3.68 billion in 2025 to $4.06 billion in 2026. - The market is expected to reach $5.96 billion by 2030. - That implies a 10.1% compound annual growth rate through the forecast period. - North America held the largest market share in 2025. - Asia-Pacific is forecast to be the fastest-growing regional market. - The report covers South East Asia, Western Europe, Eastern Europe, South America, the Middle East and Africa.

The details: - Biofeedback devices are electronic instruments that track physiological signals and provide real-time feedback. - The devices measure live data such as heart rate, muscle tension and brain activity. - Users can use that feedback to consciously regulate bodily functions for health or performance goals. - Historical growth has been supported by greater awareness of mind-body therapies. - Broader acceptance of non-pharmacological treatments has also supported demand. - Wellness and rehabilitation programs have expanded use cases. - Better sensor precision has improved device capability. - Consumer-friendly biofeedback tools are more widely available. - Looking ahead, demand is being driven by digital mental health solutions, telehealth and remote therapy. - AI-powered feedback analytics are another expected growth driver. - Preventive healthcare and self-regulation technologies are adding momentum. - The report highlights wearable devices, remote physiological monitoring, mobile health integrations, home-based therapy and stress management as key trends. - The report also says biofeedback can help users manage stress, anxiety and other health concerns through immediate feedback and self-adjustment. - A sample report is available here. - The full report is available here.

Between the lines: - The forecast points to a market shaped by consumer health behavior as much as clinical demand. - Stress-related disorders are a major tailwind because they create demand for tools that can support relaxation and self-monitoring. - The American Psychiatric Association reported in May 2024 that 43% of US adults experienced heightened anxiety in 2024, up from 37% in 2023 and 32% in 2022. - That rise helps explain why biofeedback devices are gaining relevance as stress management tools. - The report’s emphasis on remote and mobile formats suggests the category is adapting to care models that reach beyond the clinic.

What’s next: - The market is expected to keep expanding through 2030 as digital mental health, telehealth and home-use therapies gain traction. - Wearable devices and AI-enhanced analytics are likely to shape the next phase of product development. - Growth in Asia-Pacific will be a key regional trend to watch. - The report says its 2026 edition adds market attractiveness scoring, TAM analysis, company scoring matrix graphics and tables, Excel dashboards, market hotspot infographics, key technologies and future trends, and updated graphics and tables. - More information is available through the company’s report and sample links.